Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials - Huang, Ze-Hao; Ma, Xiao-Wen; Zhang, Jing; Li, Xiao; Lai, Na-Lin; Zhang, Sheng-Xiao (BMC cancer, 2018)
Keywords: Antineoplastic Agents, Immunological - pharmacology; Antineoplastic Agents, Immunological - therapeutic use; Biomedical and Life Sciences; Biomedicine; Cancer; Cancer Research; Cancer therapies; Care and treatment; Cetuximab; Cetuximab - pharmacology; Cetuximab - therapeutic use; Chemoradiotherapy; Chemotherapy; Clinical trials; Combined modality therapy; Diarrhea; Disease control; Drug therapy; Epidermal growth factor; Epidermal growth factor receptor; Esophageal cancer; Esophageal Neoplasms - drug therapy; Esophageal Neoplasms - mortality; Esophageal Neoplasms - pathology; Esophagus; Exanthema; Gene amplification; Health Promotion and Disease Prevention; Health risk assessment; Humans; Immunotherapy; Medical and radiation oncology; Medical prognosis; Medicine/Public Health; Meta-analysis; Metastases; Metastasis; Methods; Monoclonal antibodies; Odds Ratio; Oncology; Patient outcomes; Patients; Prognosis; Radiation therapy; Randomized Controlled Trials as Topic; Research Article; Response rates; Surgical Oncology; Survival; Survival Analysis; Targeted cancer therapy; Treatment Outcome; Tumors; Cetuximab; Esophageal cancer; Epidermal growth factor receptor; Meta-analysis